Introduction
The flavonoids are related to numerous cluster of natural polyphenolic compounds. Natural chromones (benzopyran-4-ones) are represented in most cases by flavones (2- arylbenzopyran-4-ones) and isoflavones (3-arylbenzopyran-4-ones) . The numeration of such system is also given in Figure 1 .
The replacement of aryl radical in the isoflavone molecules on such pharmacophores as nitrogen heterocycles leads to the new structures, named "double drugs", which are potential bispharmacophoric medicine remedy -3-azahetarylchromones. The researches that have been reported on the 3-hetarylchromones are both extensive and varied [1] [2] [3] [4] . The hydrogenated chromone derivatives are of indubitable interest, owing to a wide spectrum of biological activity (estrogenic, anti-cancer, antiinflammatory, antioxidative, hepatoprotective, antimicrobial, hypolipidemic etc.) [5] . Considerable less information has been reported on the hydrogenated analogues of 3-hetarylchromones. In this mini review, the authors make attempt to reflect up-to-date state of researches on 3-hetarylchroman-4-ones' synthesis and biological activity.
Results and discussion
There are three basic approaches for 3-hetarylchroman-4-ones' preparation:
nucleophilic substitution in 3-bromochroman-4-ones, cyclization of 2-hydroxy-α-hetarylacetophenones, reduction/hydrogenation of 3-hetarylchromones.
Nucleophilic substitution in 3-bromochroman-4-ones
It is possible to synthesize 3-hetarylchroman-4-ones by nucleophilic substitution in 3-bromochroman-4-ones, although this method is of no practical significance for reasons that are discussed below.
It is known that 3-bromochroman-4-ones readily eliminate hydrogen bromide in the presence of alkali to form chromones. It is interesting to note that treatment of 3-bromochroman-4-one with diethylamine in aqueous solution at room temperature was reported to give the diethylaminovinyl ketone, which could be readily converted into chromone by the action of ethereal hydrogen chloride [6] .
Colonge and Guyot [7] described the reaction of 3-bromochroman-4-one 1 with piperidine and suggested the isolated product to be 3-piperidinochroman-4-one 2 (Scheme 1). Further reinvestigation [8] indicated that the isolated compound was not 2, but identical with ohydroxy--piperidinoacrylophenone 3, obtained according to Winter and Hamilton [9] after treatment of chromone with piperidine. It can be assumed that the first step of the above reaction consists in the formation of chromone with subsequent production of 3. However, as the formation of 2 could not be excluded, the treatment of 1 was performed with the calculated amount (2 moles) of piperidine in dry benzene. After removal of the main product 3 the expected piperidinochromanone 2 could be isolated as its hydrochloride in poor yield (8 %) . Varying degrees of dehydrohalogenation of 3-bromochroman-4-ones took place, giving the 6 corresponding chromones 6 in addition to the desired compounds of formula 4. The side reaction giving chromones 6 could not be eliminated by changing the solvent and temperature or by using imidazole derivatives such as its sodium or silver salt or trimethylsililimidazole [10] . The 3-(imidazol-1-yl)chroman-4-one series was obtained by modifying a substituent on the phenylene ring of the parent compounds (R group in Scheme 2) [11] .
By reacting pyrazole with 3-bromochroman-4-ones under similar conditions the unreacted materials were recovered [10] . In the references [15, 16] it is shown that 3-(2-pyridinyl)chroman-4-one N-oxides 10 and In the search for new compounds of pharmacological interest a number of derivatives containing the imidazole and the chroman ring in the same molecule were prepared, as exemplified in Scheme 6 [10, 11] . formaldehyde took place giving a compound to which the authors [10] assigned the structure of
19, 20
AcOH 18 by paraformaldehyde in acetic acid at 90-100C gave the corresponding 3-triazolylchromanones 29 and 30 in low to moderate yield [12, 20, 21] .
In the latter reaction in addition to 3-(4H-1,2,4-triazol-4-yl)chroman-4-ones 30, the corresponding hydroxymetyl derivatives 31
were obtained as by-products [12] . 
Hydrogenation of 3-hetarylchromones
When a chromone is subjected to hydrogenation/reduction, several products can be isolated: chroman-4-ones, chroman-4-ols, chromenes and chromans. Some of them were used for the hydrogenation of 3-hetarylchromones.
With palladium on carbon
Hydrogenation on Pd/C is the most widely used method for reduction of chromones.
At first, selective hydrogenation of the isoflavones was accomplished by Szabo et al. [25, 26] . The selectivity in the formation of dihydro-isoflavones was found dependent on the supplier of Pd/C and pH-dependent.
A starting point for hydrogenation of an unknown chromone can be a "titration with hydrogen" over Pd/C. A problem with this method is a strong dependence of the hydrogenation feasibility on substrate and on hydrogen pressure.
A successful application of "titration with hydrogen" is illustrated by Khilya et al., who showed that the 3-(2-pyridyl)-7-hydroxychromone 37 could be hydrogenated to 
Transfer hydrogenation
In the chromone series, catalytic transfer Cozzi et al. [17, 28] have studied the reduction of (un)substituted 3-(1H-imidazol-1-yl)-and 3- 
Homogeneous hydrogenation
Homogeneous catalytic hydrogenation is an important tool for the chemistry of chroman-4-ones since it could proceed enantioselectivity.
Catalytic homogeneous hydrogenation of 7-methoxyisoflavone [30] [31] [32] and its pyridine analogues [31, 32] was first achieved in the presence of cationic iridium complexes. 
